Design, synthesis, and structure-activity relationships of novel imidazo[4,5-c]pyridine derivatives as potent non-nucleoside inhibitors of hepatitis C virus NS5B-Reference-Cited by-同舟云学术

Design, synthesis, and structure-activity relationships of novel imidazo[4,5-c]pyridine derivatives as potent non-nucleoside inhibitors of hepatitis C virus NS5B

Published:2018-05 Issue:9 Volume:26 Page:2621-2631
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Liu Moyi,Xu Qiaoling,Guo Su,Zuo Ruixi,Hong Yue,Luo Yong,Li Yingxiu,Gong Ping,Liu Yajing

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference29 articles.

1. Global epidemiology of Hepatitis C virus infection;Shepard;Lancet Infect Dis,2005

2. Global epidemiology and genotype distribution of the Hepatitis C virus infection;Gower;J Hepatol,2014

3. Treating viral hepatitis C: efficacy, side effects, and complications;Manns;Gut,2006

4. VX-950, a novel hepatitis C Virus (HCV) NS3−4A protease inhibitor, exhibits potent antiviral activities in HCV replicon cells;Lin;Antimicrob Agents Chemother,2006

5. Preclinical profile of VX-950, a potent, selective, and orally bioavailable inhibitor of hepatitis C Virus NS3−4A serine protease;Perni;Antimicrob Agents Chemother,2006

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advancements in NS5B inhibitors (2011-2021): Structural insights, SAR studies and clinical status;Journal of Molecular Structure;2023-12

2. A Literature Review Focusing on the Antiviral Activity of [1,2,4] and [1,2,3]-triazoles;Mini-Reviews in Medicinal Chemistry;2023-11-24

3. Phenylpyrazolone-1,2,3-triazole Hybrids as Potent Antiviral Agents with Promising SARS-CoV-2 Main Protease Inhibition Potential;Pharmaceuticals;2023-03-20

4. Pharmacoinformatics-based strategy in designing and profiling of some Pyrazole analogues as novel hepatitis C virus inhibitors with pharmacokinetic analysis;Egyptian Journal of Basic and Applied Sciences;2023-03-13

5. Insight into non-nucleoside triazole-based systems as viral polymerases inhibitors;European Journal of Medicinal Chemistry;2023-03